Retinal Surgery London Ltd - Accounts to registrar (filleted) - small 18.2

Retinal Surgery London Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.2.0.596 09399902 director 1.2.18 31.1.19 31.1.19 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure093999022018-01-31093999022019-01-31093999022018-02-012019-01-31093999022017-01-31093999022017-02-012018-01-31093999022018-01-3109399902ns14:PoundSterling2018-02-012019-01-3109399902ns10:Director12018-02-012019-01-3109399902ns10:PrivateLimitedCompanyLtd2018-02-012019-01-3109399902ns10:SmallEntities2018-02-012019-01-3109399902ns10:AuditExempt-NoAccountantsReport2018-02-012019-01-3109399902ns10:SmallCompaniesRegimeForDirectorsReport2018-02-012019-01-3109399902ns10:SmallCompaniesRegimeForAccounts2018-02-012019-01-3109399902ns10:FullAccounts2018-02-012019-01-3109399902ns10:OrdinaryShareClass12018-02-012019-01-3109399902ns10:OrdinaryShareClass22018-02-012019-01-3109399902ns10:OrdinaryShareClass32018-02-012019-01-3109399902ns10:RegisteredOffice2018-02-012019-01-3109399902ns5:CurrentFinancialInstruments2019-01-3109399902ns5:CurrentFinancialInstruments2018-01-3109399902ns5:ShareCapital2019-01-3109399902ns5:ShareCapital2018-01-3109399902ns5:RetainedEarningsAccumulatedLosses2019-01-3109399902ns5:RetainedEarningsAccumulatedLosses2018-01-310939990212018-02-012019-01-3109399902ns5:FurnitureFittings2018-01-3109399902ns5:FurnitureFittings2018-02-012019-01-3109399902ns5:FurnitureFittings2019-01-3109399902ns5:FurnitureFittings2018-01-3109399902ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-01-3109399902ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-01-3109399902ns10:OrdinaryShareClass12019-01-3109399902ns10:OrdinaryShareClass22019-01-3109399902ns10:OrdinaryShareClass32019-01-3109399902ns10:Director112018-01-3109399902ns10:Director112017-01-3109399902ns10:Director112018-02-012019-01-3109399902ns10:Director112017-02-012018-01-3109399902ns10:Director112019-01-3109399902ns10:Director112018-01-31


REGISTERED NUMBER: 09399902















Unaudited Financial Statements for the Year Ended 31 January 2019

for

Retinal Surgery London Ltd

Retinal Surgery London Ltd (Registered number: 09399902)






Contents of the Financial Statements
for the Year Ended 31 January 2019




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Retinal Surgery London Ltd

Company Information
for the Year Ended 31 January 2019







DIRECTOR: Dr S C Wong





REGISTERED OFFICE: 49 Peter Street
Manchester
M2 3NG





REGISTERED NUMBER: 09399902





ACCOUNTANTS: Veritas Accountants & Advisory Limited
49 Peter Street
Manchester
M2 3NG

Retinal Surgery London Ltd (Registered number: 09399902)

Balance Sheet
31 January 2019

2019 2018
Notes £    £   
FIXED ASSETS
Tangible assets 4 4,504 5,697

CURRENT ASSETS
Debtors 5 128,438 100,520
Cash at bank 254,247 178,127
382,685 278,647
CREDITORS
Amounts falling due within one year 6 (49,088 ) (53,739 )
NET CURRENT ASSETS 333,597 224,908
TOTAL ASSETS LESS CURRENT
LIABILITIES

338,101

230,605

PROVISIONS FOR LIABILITIES (856 ) (1,082 )
NET ASSETS 337,245 229,523

CAPITAL AND RESERVES
Called up share capital 7 101 101
Retained earnings 337,144 229,422
SHAREHOLDERS' FUNDS 337,245 229,523

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and
387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the
company as at the end of each financial year and of its profit or loss for each financial year in
accordance with the requirements of Sections 394 and 395 and which otherwise comply with
the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.

Retinal Surgery London Ltd (Registered number: 09399902)

Balance Sheet - continued
31 January 2019


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director on 18 October 2019 and were signed by:





Dr S C Wong - Director


Retinal Surgery London Ltd (Registered number: 09399902)

Notes to the Financial Statements
for the Year Ended 31 January 2019

1. COMPANY INFORMATION

Retinal Surgery London Ltd is a private company, limited by shares , registered in Not
specified/Other. The company's registered number and registered office address can be
found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the director is required to make
judgements, estimates and assumptions about the carrying amount of assets and liabilities
that are not readily apparent from other sources. The estimates and associated assumptions
are based on historical experience and other factors that are considered to be relevant.
Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to
accounting estimates are recognised in the period in which the estimate is revised where the
revision affects only that period, or in the period of the revision and future periods where the
revision affects both current and future periods.

There have been no critical judgements, estimates or assumptions made in the preparation
of these financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding
discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or
valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual
values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between
the sale proceeds and the carrying value of the asset, and is credited or charged to the profit
or loss.


Retinal Surgery London Ltd (Registered number: 09399902)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2019

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement
of Income and Retained Earnings, except to the extent that it relates to items recognised in
other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that
have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not
reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in
periods different from those in which they are recognised in financial statements. Deferred
tax is measured using tax rates and laws that have been enacted or substantively enacted
by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it
is probable that they will be recovered against the reversal of deferred tax liabilities or other
future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the
company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2018 - 2 ) .

Retinal Surgery London Ltd (Registered number: 09399902)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2019

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 February 2018 10,182
Additions 1,803
At 31 January 2019 11,985
DEPRECIATION
At 1 February 2018 4,485
Charge for year 2,996
At 31 January 2019 7,481
NET BOOK VALUE
At 31 January 2019 4,504
At 31 January 2018 5,697

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Trade debtors 128,438 96,812
Other debtors - 3,708
128,438 100,520

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Corporation tax payable 45,023 47,467
Other creditors - 48
PAYE control account 1,027 (1,765 )
Wages control account (667 ) (167 )
Directors' current accounts 591 93
Accrued expenses 3,114 8,063
49,088 53,739

Retinal Surgery London Ltd (Registered number: 09399902)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2019

7. CALLED UP SHARE CAPITAL




Allotted, issued and fully paid:
Number: Class: Nominal 2019 2018
value: £    £   
60 Ordinary A 1 60 60
40 Ordinary B 1 40 40
1 Ordinary C 1 1 1
101 101

Ordinary A Shares confer on the holders the right to vote upon any resolution proposed at
any general meeting of the company.

Ordinary B Shares do not confer on the holders the right to vote upon any resolution
proposed at any general meeting of the company.

Ordinary C Shares have no voting or distribution rights. Each share has a right to dividends
at the discretion of the A and B shareholders.

The A, B and C shares rank pari passu in terms of capital distribution rights.

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended
31 January 2019 and 31 January 2018:

2019 2018
£    £   
Dr S C Wong
Balance outstanding at start of year (93 ) 10,281
Amounts advanced 73,006 164,239
Amounts repaid (73,504 ) (174,613 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (591 ) (93 )

The loan is repayable on demand and no interest was charged during the year.

9. CONTROL

The ultimate controlling party is Dr S C Wong by virtue of his 100% holding of the voting
share capital.